Opinions of community pharmacists on the value of a cardiovascular polypill as a means of improving medication compliance

International Journal of Pharmacy Practice

Volumn 20, Issue 3, 2012, Pages 155-163

  Burns, Kharis ^a   Turnbull, Fiona ^a   Patel, Anushka ^a   Peiris, David ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

cardiovascular polypill; medication adherence; medication compliance; pharmacist

Indexed keywords

CARDIOVASCULAR AGENT;

ARTICLE; AUSTRALIA; CARDIOVASCULAR DISEASE; DRUG COST; DRUG RESEARCH; HEALTH CARE COST; HUMAN; PATIENT COMPLIANCE; PHARMACIST; PHARMACIST ATTITUDE; POLYPHARMACY; PRIORITY JOURNAL; QUESTIONNAIRE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; CARDIOVASCULAR DISEASES; COMMUNITY PHARMACY SERVICES; HUMANS; MEDICATION ADHERENCE; MIDDLE AGED; PHARMACISTS; QUESTIONNAIRES;

EID: 84860606316     PISSN: 09617671     EISSN: 20427174     Source Type: Journal    
DOI: 10.1111/j.2042-7174.2011.00175.x     Document Type: Article

References (35)

1. Murray C, Lopez A,. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997; 349: 1269-1276.
2. Bonow R, et al,. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 2002; 106: 1602-1605.
3. Mathers C, Loncar D,. Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Med 2006; 3: e442.
4. World Health Organization. World Health Report 2002; Reducing Risk, Promoting Healthy Life. Geneva: World Health Organization, 2002.
5. Petkova V,. Physicians, pharmacists and patients' compliance with chronic treatment in Bulgaria. Pharmacoepidemiol Drug Saf 2006; 15: 607-612.
6. Heeley EL, et al,. Cardiovascular risk perception and evidence-practice gaps in Australian general practice (the AusHEART study). Med J Aust 2010; 192: 254-259.
7. Hobbs F, Erhadt L,. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract 2002; 19: 596-604.
8. Davis M,. Current targets: where are we going? Heart 2003; 89: ii6-ii9.
9. Bailey J, et al,. Risk factors for antihypertensive medication refill failure by patients. Clin Ther 1996; 18: 1252-1262.
10. Barat I, et al,. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol 2001; 51: 615-622.
11. Miller NH, et al,. The multilevel compliance challenge: recommendations for a call to action-a statement for healthcare professionals. Circulation 1997; 95: 1085-1090.
12. Paes A, et al,. Impact of dosage frequency on patient compliance. Diabetes Care 1997; 20: 1512-1517.
13. Nunes V, et al,. Medicines Adherence: Involving Patients in Decisions about Prescribed Medicines and Supporting Adherence. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners, 2009.
14. Shaw E, et al,. Factors associated with noncompliance of patients taking antihypertensive medications. Hosp Pharm 1995; 30: 201-203.
15. Wald N, Law M,. A strategy to reduce cardiovascular disease by more than 80%. Br Med J 2003; 326: 1419-1424.
16. Yusuf S,. Two decades of progress in preventing vascular disease. Lancet 2002; 360: 2-3.
17. World Health Organization. Secondary Prevention of Non-Communicable Disease in Low and Middle Income Countries through Community-Based and Health Service Interventions. World Health Organization-Wellcome Trust meeting report, 1-3 August 2001. Geneva: World Health Organization, 2002.
18. Lonn E, Yusuf S,. Polypill: the evidence and the promise. Curr Opin Lipidol 2009; 20: 453-459.
19. Machado M, et al,. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother 2007; 41: 1770-1781.
20. Van Wijk BLG, et al,. Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother 2005; 39: 319-328.
21. Saini BM, et al,. Factors influencing Australian community pharmacists'willingness to participate in research projects-an exploratory study. Int J Pharm Pract 2006; 14: 179-188.
22. Patton M,. Qualitative Research. Encyclopedia of Statistics in Behavioral Science, 3rd edn. Thousand Oaks, CA: Sage Publications, 2002.
23. The Allen Consulting Group. Community Pharmacy in the Australian Capital Territory: Review of Services and Competitive Issues. Final Report to ACT Health. Sydney: The Allen Consulting Group, 2005.
24. Australian Institute of Health and Welfare. Health and Community Services Labour Force 2006. Canberra: Australian Institute of Health and Welfare, 2009.
25. Lynch T,. Medication costs as a primary cause of nonadherence in the elderly. Consult Pharm 2006; 21: 143-146.
26. Balkrishnan R,. The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care 2005; 43: 517-520.
27. Simpson RJ Jr,. Challenges for improving medication adherence. JAMA 2006; 296: 2614-2616.
28. Department of Health and Ageing. About the PBS. 2011. www.pbs.gov.au/info/about-the-pbs (accessed 22 February 2010).
29. Department of Human Services, Australian Government. Payments. 2011. www.centrelink.gov.au/internet/internet.nsf/payments/conc-cards-hcc.htm (accessed 29 April 2011).
30. Krueger KP, et al,. Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative. J Am Pharm Assoc 2003; 43: 668-678.
31. Guerrault MN, et al,. [Study of the usefulness of pharmacist consultations for patients on antiretroviral regimens]. Presse Med 2005; 34 (20 Pt 2): 1563-1570.
32. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002; 324: 71-86.
33. Heneghan CJ, et al,. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev 2008; 1: CD005025.
34. Lee JK, et al,. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 2006; 296: 2563-2571.
35. MacLaughlin EJ, et al,. Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging 2005; 22: 231-255.